| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.YEXCR.2013.10.020 |
| P698 | PubMed publication ID | 24211747 |
| P2093 | author name string | Yongming Qiu | |
| Qing Mao | |||
| Jianwei Ge | |||
| Jin Lan | |||
| Pin Guo | |||
| Quanmin Nie | |||
| Liemei Guo | |||
| P2860 | cites work | Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line | Q38288867 |
| Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia | Q38343194 | ||
| Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma | Q39235192 | ||
| MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene | Q39305395 | ||
| Transcriptional modulation of micro-RNA in human cells differing in radiation sensitivity | Q39693567 | ||
| DNA repair after irradiation in glioma cells and normal human astrocytes | Q40092752 | ||
| Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavir | Q40136467 | ||
| ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation | Q40570996 | ||
| Double strand break repair by homologous recombination is regulated by cell cycle-independent signaling via ATM in human glioma cells | Q40595350 | ||
| ATM is a target for positive regulation by E2F-1. | Q42806424 | ||
| Counteracting tumor radioresistance by targeting DNA repair | Q44647808 | ||
| Expression of ATM protein and its relationship with p53 in pancreatic carcinoma with tissue array | Q47733277 | ||
| Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells | Q21563320 | ||
| MicroRNA-26a/b and their host genes cooperate to inhibit the G1/S transition by activating the pRb protein | Q24601263 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo | Q24657924 | ||
| Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage | Q24672492 | ||
| MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
| ATM phosphorylates histone H2AX in response to DNA double-strand breaks | Q28188651 | ||
| Lin28-let7 modulates radiosensitivity of human cancer cells with activation of K-Ras | Q28267417 | ||
| DNA damage responses: mechanisms and roles in human disease: 2007 G.H.A. Clowes Memorial Award Lecture | Q28276038 | ||
| Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation | Q28287476 | ||
| ATM: from gene to function | Q28611464 | ||
| Malignant astrocytic glioma: genetics, biology, and paths to treatment | Q29618156 | ||
| Atm-deficient mice: a paradigm of ataxia telangiectasia | Q29619532 | ||
| Serine/threonine protein phosphatase 6 modulates the radiation sensitivity of glioblastoma | Q30428996 | ||
| Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
| DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis | Q33814324 | ||
| Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX | Q34031720 | ||
| miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. | Q34043212 | ||
| H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy. | Q34089263 | ||
| Phosphatases in the cellular response to DNA damage. | Q34198570 | ||
| Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration | Q34229869 | ||
| Aggressive treatment is appropriate for glioblastoma multiforme patients 70 years old or older: a retrospective review of 206 cases | Q34722872 | ||
| Tying the loose ends together in DNA double strand break repair with 53BP1. | Q35082739 | ||
| Characteristics of gamma-H2AX foci at DNA double-strand breaks sites | Q35191534 | ||
| Role of cell cycle in mediating sensitivity to radiotherapy | Q35826593 | ||
| Revival of the abandoned therapeutic wortmannin by nanoparticle drug delivery. | Q35991577 | ||
| Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents | Q36395924 | ||
| Treatment of glioblastoma multiforme: a new standard | Q36420125 | ||
| Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy | Q36431591 | ||
| ATM activation and DNA damage response | Q36800838 | ||
| DNA repair by homologous recombination, but not by nonhomologous end joining, is elevated in breast cancer cells. | Q37229934 | ||
| Phase II preradiation R115777 (tipifarnib) in newly diagnosed GBM with residual enhancing disease | Q37284331 | ||
| Molecular mechanisms of ultraviolet radiation-induced DNA damage and repair | Q37826346 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 200-208 | |
| P577 | publication date | 2013-11-05 | |
| P1433 | published in | Experimental Cell Research | Q1524289 |
| P1476 | title | MiR-26a enhances the radiosensitivity of glioblastoma multiforme cells through targeting of ataxia-telangiectasia mutated | |
| P478 | volume | 320 |
| Q35198369 | ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levels. |
| Q57161414 | Aberrant miRNAs Regulate the Biological Hallmarks of Glioblastoma |
| Q49023583 | Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors |
| Q64067528 | Deregulated MicroRNA Signature Following Glioblastoma Irradiation |
| Q38606228 | Genomic integrity and the ageing brain |
| Q38393328 | Glioblastoma: molecular pathways, stem cells and therapeutic targets |
| Q38848860 | Inhibition of miR-630 enhances the cell resistance to radiation by directly targeting CDC14A in human glioma |
| Q38736898 | Loss of miR-26a-5p promotes proliferation, migration, and invasion in prostate cancer through negatively regulating SERBP1. |
| Q35140218 | MiR-124 Radiosensitizes human colorectal cancer cells by targeting PRRX1 |
| Q38819398 | MiR-218-5p inhibits the stem cell properties and invasive ability of the A2B5⁺CD133⁻ subgroup of human glioma stem cells |
| Q38828580 | MiR-26a enhances the sensitivity of gastric cancer cells to cisplatin by targeting NRAS and E2F2 |
| Q38958486 | MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14). |
| Q37476413 | MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis |
| Q49790324 | MicroRNA-26a and Tumor |
| Q38827487 | MicroRNA-378g enhanced radiosensitivity of NPC cells partially by targeting protein tyrosine phosphatase SHP-1. |
| Q41116642 | MicroRNA-590-3p enhances the radioresistance in glioblastoma cells by targeting LRIG1. |
| Q28829013 | MicroRNAs Used in Combination with Anti-Cancer Treatments Can Enhance Therapy Efficacy |
| Q38497875 | MicroRNAs and cell cycle of malignant glioma |
| Q26747273 | MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics |
| Q41239908 | Targeting MicroRNAs in Prostate Cancer Radiotherapy |
| Q99591126 | The Role of Exosomes in Stemness and Neurodegenerative Diseases-Chemoresistant-Cancer Therapeutics and Phytochemicals |
| Q38796729 | The role of microRNA-26a in human cancer progression and clinical application |
| Q49762971 | miR‑328‑3p enhances the radiosensitivity of osteosarcoma and regulates apoptosis and cell viability via H2AX. |
| Q89720471 | microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy |
Search more.